Top

Published in:

01-03-2017 | Letter to the Editor

Intravascular lymphoma: look through the small vessels

Authors: Concepción Prats-Martín, Emilio Franco-Macías, Rosario M. Morales-Camacho, Olga Pérez, M. Teresa Vargas, Fátima de la Cruz Vicente, Juan J. Borrero, Ricardo Bernal, José A. Pérez-Simón

Published in: Annals of Hematology | Issue 3/2017

Excerpt

Dear Editor, …

Available only for authorised users

Van Dongen JJ, Lhermitte L, Böttcher S et al (2012) EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 26:1908–1975CrossRefPubMedPubMedCentral

Ponzoni M, Ferreri AJ, Campo E et al (2007) Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 25:3168–3173CrossRefPubMed

Song DK, Boulis NM, McKeever PE, Quint DJ (2002) Angiotropic large cell lymphoma with imaging characteristics of CNS vasculitis. Am J Neuroradiol 23:239–242PubMed

Van Rhenen A, Van de Donk NW (2014) Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities: intravascular lymphoma. Blood 123:2914CrossRefPubMed

Ferreri AJ, Campo E, Seymour JF et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127:173–183CrossRefPubMed

Khoury H, Lestou VS, Gascoyne RD et al (2003) Multicolor karyotyping and clinicopathological analysis of three intravascular lymphoma cases. Mod Pathol 16:716–724CrossRefPubMed

Rashid R, Johnson RJ, Morris S et al (2006) Intravascular large B-cell lymphoma associated with a near-tetraploid karyotype, rearrangement of BCL6, and a t(11;14)(q13;q32). Cancer Genet Cytogenet 171:101–104CrossRefPubMed

Kato K, Ohno Y, Kamimura T et al (2014) Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma. Bone Marrow Transplantation 49(12):1543–1544

Title: Intravascular lymphoma: look through the small vessels
Authors: Concepción Prats-Martín
Emilio Franco-Macías
Rosario M. Morales-Camacho
Olga Pérez
M. Teresa Vargas
Fátima de la Cruz Vicente
Juan J. Borrero
Ricardo Bernal
José A. Pérez-Simón
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 3/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-016-2874-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Intravascular lymphoma: look through the small vessels

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2017

Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population

Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment

Evidence for a role of decitabine in the treatment of myeloid sarcoma

Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012

Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page